Your browser doesn't support javascript.
loading
Risk factors for anaemia in human immunodeficiency virus/hepatitis C virus-coinfected patients treated with interferon plus ribavirin.
Bani-Sadr, F; Goderel, I; Penalba, C; Billaud, E; Doll, J; Welker, Y; Cacoub, P; Pol, S; Perronne, C; Carrat, F.
Affiliation
  • Bani-Sadr F; Groupe Hospitalier Universitaire Est, Université Paris, INSERM U707, Paris, France. firouze.bani-sadr@tnn.ap-hop-paris.fr
J Viral Hepat ; 14(9): 639-44, 2007 Sep.
Article in En | MEDLINE | ID: mdl-17697016
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Ribavirin / HIV Infections / Interferon-alpha / Hepatitis C, Chronic / Anemia Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: J Viral Hepat Journal subject: GASTROENTEROLOGIA Year: 2007 Document type: Article Affiliation country: Country of publication:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Ribavirin / HIV Infections / Interferon-alpha / Hepatitis C, Chronic / Anemia Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: J Viral Hepat Journal subject: GASTROENTEROLOGIA Year: 2007 Document type: Article Affiliation country: Country of publication: